- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Nikki Reeves
Events 27 results
Conference
May 15, 2024
Annual King & Spalding California Life Sciences Summit
Speaking Engagement
January 23, 2024
Nikki Reeves to Speak at ACI’s Advanced Legal, Regulatory and Compliance Forum on OTC Drugs
Webinar
January 17, 2024
Year in Review for Drug and Device Advertising and Promotion – Lessons Learned from 2023 FDA Enforcement Letters and Other Key Developments
Webinar
December 11, 2023
#Sponsored: Influencer Marketing 201 for Pharmaceutical and Medical Device Companies
Conference
November 7, 2023
Pharmaceutical University 2023
Speaking Engagement
October 25, 2023
Nikki Reeves, Seth Lundy, Brian Bohnenkamp to Speak at Pharmaceutical Compliance Congress Conference
Speaking Engagement
October 10, 2023
Nikkie Reeves and Gillian Russell to Speak at Seton Hall Law’s US Healthcare Compliance Certificate Program (USHCCP)
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Conference
March 8, 2023
California Life Sciences Summit
Speaking Engagement
February 23, 2023
Nikki Reeves, Heather Banuelos, Gillian Russell to Speak at DIA Global’s Advertising and Promotion Regulatory Affairs Conference
Webinar
January 24, 2023
Year in Review for Drug and Device Advertising and Promotion: Lessons Learned From 2022 FDA Enforcement Letters and Other Key Developments
Conference
November 1, 2022
Pharmaceutical University 2022